您的位置: 首页 > 农业专利 > 详情页

ANTICORPS DU RÉCEPTEUR DU FACTEUR DE CROISSANCE ANTI-ÉPIDERMIQUE (EGFR)
专利权人:
Ltd.;Henlix Biotech Co.
发明人:
申请号:
EP19201262.3
公开号:
EP3613433A1
申请日:
2015.05.29
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
Provided are anti-epidermal growth factor receptor (EGFR) antibodies, aglycosylated CDR-H2 anti-EGFR antibodies, and antigen binding fragments thereof. Also provided are isolated nucleic acid molecules that encode the anti-EGFR antibodies or antigen binding fragments thereof, related expression vectors, and host cells. Provided are methods of making anti-epidermal growth factor receptor (EGFR) antibodies, aglycosylated CDR-H2 anti-EGFR antibodies, and antigen binding fragments thereof. Also provided are related pharmaceutical compositions and methods of their use to treat subjects.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充